A detailed history of Global Financial Private Client, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Global Financial Private Client, LLC holds 56 shares of TECH stock, worth $3,978. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56
Previous 56 -0.0%
Holding current value
$3,978
Previous $4.01 Million 11.57%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 15, 2024

BUY
$80.67 - $352.29 $3,388 - $14,796
42 Added 300.0%
56 $4.64 Million
Q4 2019

May 15, 2024

BUY
$189.68 - $222.09 $2,655 - $3,109
14 New
14 $3.07 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.79B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Global Financial Private Client, LLC Portfolio

Follow Global Financial Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.